nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—vertebral column—osteoporosis	0.0686	0.947	CbGeAlD
Cysteamine—NPY2R—Circadian rythm related genes—ID4—osteoporosis	0.0178	0.0616	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—PRDX3—osteoporosis	0.00821	0.0285	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00659	0.0229	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—PTH1R—osteoporosis	0.00543	0.0188	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CALCR—osteoporosis	0.00543	0.0188	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—PTH1R—osteoporosis	0.0052	0.018	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CALCR—osteoporosis	0.0052	0.018	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CNR2—osteoporosis	0.00459	0.0159	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.00457	0.0158	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CNR2—osteoporosis	0.0044	0.0153	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—COL1A2—osteoporosis	0.00431	0.0149	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00408	0.0142	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—WNT1—osteoporosis	0.00391	0.0136	CbGpPWpGaD
Cysteamine—MPO—bone marrow—osteoporosis	0.00387	0.0534	CbGeAlD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00365	0.0126	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.0035	0.0121	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—SOD2—osteoporosis	0.00345	0.012	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PTH1R—osteoporosis	0.00307	0.0106	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CALCR—osteoporosis	0.00307	0.0106	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.00304	0.0105	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PTH1R—osteoporosis	0.00294	0.0102	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CALCR—osteoporosis	0.00294	0.0102	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—PTH—osteoporosis	0.00285	0.00988	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—SOD2—osteoporosis	0.00281	0.00973	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CALCR—osteoporosis	0.00279	0.00966	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PTH1R—osteoporosis	0.00279	0.00966	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CNR2—osteoporosis	0.00278	0.00963	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—PTH—osteoporosis	0.00273	0.00948	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—GPX1—osteoporosis	0.00268	0.00928	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CALCR—osteoporosis	0.00267	0.00926	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PTH1R—osteoporosis	0.00267	0.00926	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CNR2—osteoporosis	0.00266	0.00923	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—WNT1—osteoporosis	0.00261	0.00906	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—WNT1—osteoporosis	0.0025	0.00868	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—MTHFR—osteoporosis	0.00247	0.00857	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—ADCY5—osteoporosis	0.00244	0.00847	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—MGLL—osteoporosis	0.00244	0.00845	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.00243	0.00844	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—PTHLH—osteoporosis	0.00236	0.00819	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—ADCY5—osteoporosis	0.00234	0.00812	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—MGLL—osteoporosis	0.00234	0.0081	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL1B—osteoporosis	0.00233	0.00808	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—LEP—osteoporosis	0.00227	0.00788	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—PTHLH—osteoporosis	0.00226	0.00785	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—SOD2—osteoporosis	0.00223	0.00773	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MGLL—osteoporosis	0.00221	0.00767	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—POMC—osteoporosis	0.00213	0.00739	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—GPX1—osteoporosis	0.00213	0.00737	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MGLL—osteoporosis	0.00212	0.00735	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CALCA—osteoporosis	0.00208	0.00721	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—POMC—osteoporosis	0.00204	0.00708	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CALCA—osteoporosis	0.00199	0.00691	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—MTHFR—osteoporosis	0.00196	0.00681	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.00185	0.00642	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SOST—osteoporosis	0.00182	0.00631	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL1B—osteoporosis	0.0018	0.00625	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—POMC—osteoporosis	0.0018	0.00623	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SOST—osteoporosis	0.00174	0.00605	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—POMC—osteoporosis	0.00172	0.00597	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—osteoporosis	0.00169	0.00586	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CALCR—osteoporosis	0.00165	0.0057	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTH1R—osteoporosis	0.00165	0.0057	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PTH—osteoporosis	0.00161	0.00559	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTH1R—osteoporosis	0.00158	0.00547	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CALCR—osteoporosis	0.00158	0.00547	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CNR2—osteoporosis	0.00157	0.00544	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PTH—osteoporosis	0.00154	0.00536	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CNR2—osteoporosis	0.00151	0.00522	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL1B—osteoporosis	0.00147	0.00508	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PTH—osteoporosis	0.00146	0.00507	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00143	0.00495	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CNR2—osteoporosis	0.00143	0.00494	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PTH—osteoporosis	0.0014	0.00486	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00137	0.00475	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CNR2—osteoporosis	0.00137	0.00474	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL6—osteoporosis	0.00136	0.00473	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00134	0.00466	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—WNT1—osteoporosis	0.00134	0.00465	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PTHLH—osteoporosis	0.00134	0.00463	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—osteoporosis	0.00131	0.00453	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MGLL—osteoporosis	0.00131	0.00453	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—WNT1—osteoporosis	0.00129	0.00446	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PTHLH—osteoporosis	0.00128	0.00444	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LRP5—osteoporosis	0.00128	0.00442	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MGLL—osteoporosis	0.00125	0.00434	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LRP5—osteoporosis	0.00122	0.00424	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LRP6—osteoporosis	0.00122	0.00423	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PTHLH—osteoporosis	0.00121	0.0042	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CALCA—osteoporosis	0.00118	0.00407	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LRP6—osteoporosis	0.00117	0.00406	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL1B—osteoporosis	0.00117	0.00404	CbGpPWpGaD
Cysteamine—Erythema—Zoledronate—osteoporosis	0.00116	0.00182	CcSEcCtD
Cysteamine—Malnutrition—Zoledronate—osteoporosis	0.00116	0.00182	CcSEcCtD
Cysteamine—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00116	0.00182	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00116	0.00182	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PTHLH—osteoporosis	0.00116	0.00403	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00116	0.00181	CcSEcCtD
Cysteamine—Hypertension—Risedronate—osteoporosis	0.00116	0.00181	CcSEcCtD
Cysteamine—Discomfort—Ethinyl Estradiol—osteoporosis	0.00116	0.00181	CcSEcCtD
Cysteamine—Somnolence—Calcitriol—osteoporosis	0.00116	0.00181	CcSEcCtD
Cysteamine—Decreased appetite—Ibandronate—osteoporosis	0.00115	0.00181	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00115	0.00179	CcSEcCtD
Cysteamine—Fatigue—Ibandronate—osteoporosis	0.00114	0.00179	CcSEcCtD
Cysteamine—Leukopenia—Pamidronate—osteoporosis	0.00114	0.00178	CcSEcCtD
Cysteamine—Constipation—Ibandronate—osteoporosis	0.00114	0.00178	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00113	0.00177	CcSEcCtD
Cysteamine—Gastrointestinal pain—Estropipate—osteoporosis	0.00113	0.00177	CcSEcCtD
Cysteamine—Decreased appetite—Calcitriol—osteoporosis	0.00113	0.00177	CcSEcCtD
Cysteamine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00113	0.00176	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CALCA—osteoporosis	0.00113	0.00391	CbGpPWpGaD
Cysteamine—Feeling abnormal—Alendronate—osteoporosis	0.00112	0.00176	CcSEcCtD
Cysteamine—Malnutrition—Conjugated Estrogens—osteoporosis	0.00112	0.00175	CcSEcCtD
Cysteamine—Erythema—Conjugated Estrogens—osteoporosis	0.00112	0.00175	CcSEcCtD
Cysteamine—Gastrointestinal pain—Alendronate—osteoporosis	0.00111	0.00174	CcSEcCtD
Cysteamine—Constipation—Calcitriol—osteoporosis	0.00111	0.00174	CcSEcCtD
Cysteamine—Convulsion—Pamidronate—osteoporosis	0.0011	0.00173	CcSEcCtD
Cysteamine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.0011	0.00172	CcSEcCtD
Cysteamine—Hypertension—Pamidronate—osteoporosis	0.0011	0.00172	CcSEcCtD
Cysteamine—Tension—Conjugated Estrogens—osteoporosis	0.0011	0.00172	CcSEcCtD
Cysteamine—Urticaria—Estropipate—osteoporosis	0.0011	0.00172	CcSEcCtD
Cysteamine—Gastrointestinal pain—Raloxifene—osteoporosis	0.0011	0.00172	CcSEcCtD
Cysteamine—Diarrhoea—Etidronic acid—osteoporosis	0.00109	0.00171	CcSEcCtD
Cysteamine—Abdominal pain—Estropipate—osteoporosis	0.00109	0.00171	CcSEcCtD
Cysteamine—Body temperature increased—Estropipate—osteoporosis	0.00109	0.00171	CcSEcCtD
Cysteamine—Feeling abnormal—Ibandronate—osteoporosis	0.00109	0.00171	CcSEcCtD
Cysteamine—Tremor—Zoledronate—osteoporosis	0.00109	0.00171	CcSEcCtD
Cysteamine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00109	0.00171	CcSEcCtD
Cysteamine—Nervousness—Conjugated Estrogens—osteoporosis	0.00109	0.0017	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—POMC—osteoporosis	0.00109	0.00377	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00109	0.0017	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—osteoporosis	0.00108	0.00376	CbGpPWpGaD
Cysteamine—Urticaria—Alendronate—osteoporosis	0.00108	0.00169	CcSEcCtD
Cysteamine—Abdominal pain—Alendronate—osteoporosis	0.00108	0.00169	CcSEcCtD
Cysteamine—Body temperature increased—Alendronate—osteoporosis	0.00108	0.00169	CcSEcCtD
Cysteamine—Anaemia—Zoledronate—osteoporosis	0.00108	0.00168	CcSEcCtD
Cysteamine—Nervous system disorder—Risedronate—osteoporosis	0.00107	0.00168	CcSEcCtD
Cysteamine—Discomfort—Pamidronate—osteoporosis	0.00107	0.00168	CcSEcCtD
Cysteamine—Agitation—Zoledronate—osteoporosis	0.00107	0.00167	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CALCA—osteoporosis	0.00107	0.0037	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—osteoporosis	0.00106	0.00369	CbGpPWpGaD
Cysteamine—Skin disorder—Risedronate—osteoporosis	0.00106	0.00166	CcSEcCtD
Cysteamine—Gastrointestinal pain—Calcitriol—osteoporosis	0.00106	0.00166	CcSEcCtD
Cysteamine—Abdominal pain—Raloxifene—osteoporosis	0.00106	0.00166	CcSEcCtD
Cysteamine—Body temperature increased—Raloxifene—osteoporosis	0.00106	0.00166	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—osteoporosis	0.00106	0.00366	CbGpPWpGaD
Cysteamine—Urticaria—Ibandronate—osteoporosis	0.00105	0.00165	CcSEcCtD
Cysteamine—Body temperature increased—Ibandronate—osteoporosis	0.00105	0.00164	CcSEcCtD
Cysteamine—Abdominal pain—Ibandronate—osteoporosis	0.00105	0.00164	CcSEcCtD
Cysteamine—Confusional state—Pamidronate—osteoporosis	0.00105	0.00164	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—POMC—osteoporosis	0.00104	0.00362	CbGpPWpGaD
Cysteamine—Leukopenia—Zoledronate—osteoporosis	0.00104	0.00163	CcSEcCtD
Cysteamine—Anaphylactic shock—Pamidronate—osteoporosis	0.00104	0.00163	CcSEcCtD
Cysteamine—Urticaria—Calcitriol—osteoporosis	0.00103	0.00162	CcSEcCtD
Cysteamine—SST—Signaling Pathways—TLN1—osteoporosis	0.00103	0.00357	CbGpPWpGaD
Cysteamine—Abdominal pain—Calcitriol—osteoporosis	0.00103	0.00161	CcSEcCtD
Cysteamine—Body temperature increased—Calcitriol—osteoporosis	0.00103	0.00161	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CALCA—osteoporosis	0.00102	0.00355	CbGpPWpGaD
Cysteamine—Hypersensitivity—Estropipate—osteoporosis	0.00102	0.0016	CcSEcCtD
Cysteamine—Nervous system disorder—Pamidronate—osteoporosis	0.00102	0.0016	CcSEcCtD
Cysteamine—Urinary tract disorder—Estradiol—osteoporosis	0.00102	0.00159	CcSEcCtD
Cysteamine—Vomiting—Etidronic acid—osteoporosis	0.00102	0.00159	CcSEcCtD
Cysteamine—Connective tissue disorder—Estradiol—osteoporosis	0.00101	0.00158	CcSEcCtD
Cysteamine—Urethral disorder—Estradiol—osteoporosis	0.00101	0.00158	CcSEcCtD
Cysteamine—Rash—Etidronic acid—osteoporosis	0.00101	0.00158	CcSEcCtD
Cysteamine—Convulsion—Zoledronate—osteoporosis	0.00101	0.00158	CcSEcCtD
Cysteamine—Dermatitis—Etidronic acid—osteoporosis	0.00101	0.00158	CcSEcCtD
Cysteamine—Hypertension—Zoledronate—osteoporosis	0.001	0.00157	CcSEcCtD
Cysteamine—Hypersensitivity—Alendronate—osteoporosis	0.001	0.00157	CcSEcCtD
Cysteamine—Headache—Etidronic acid—osteoporosis	0.001	0.00157	CcSEcCtD
Cysteamine—Asthenia—Estropipate—osteoporosis	0.000993	0.00155	CcSEcCtD
Cysteamine—Anorexia—Pamidronate—osteoporosis	0.000991	0.00155	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TLN1—osteoporosis	0.000988	0.00342	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000984	0.00154	CcSEcCtD
Cysteamine—Discomfort—Zoledronate—osteoporosis	0.000979	0.00153	CcSEcCtD
Cysteamine—Asthenia—Alendronate—osteoporosis	0.000978	0.00153	CcSEcCtD
Cysteamine—Hypersensitivity—Ibandronate—osteoporosis	0.000978	0.00153	CcSEcCtD
Cysteamine—Convulsion—Conjugated Estrogens—osteoporosis	0.000971	0.00152	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000969	0.00152	CcSEcCtD
Cysteamine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000967	0.00151	CcSEcCtD
Cysteamine—Dyspepsia—Risedronate—osteoporosis	0.000963	0.00151	CcSEcCtD
Cysteamine—Constipation—Ethinyl Estradiol—osteoporosis	0.000959	0.0015	CcSEcCtD
Cysteamine—Confusional state—Zoledronate—osteoporosis	0.000958	0.0015	CcSEcCtD
Cysteamine—Hypersensitivity—Calcitriol—osteoporosis	0.000957	0.0015	CcSEcCtD
Cysteamine—Asthenia—Ibandronate—osteoporosis	0.000952	0.00149	CcSEcCtD
Cysteamine—Nausea—Etidronic acid—osteoporosis	0.00095	0.00149	CcSEcCtD
Cysteamine—Anaphylactic shock—Zoledronate—osteoporosis	0.00095	0.00149	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000948	0.00148	CcSEcCtD
Cysteamine—Diarrhoea—Estropipate—osteoporosis	0.000947	0.00148	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000944	0.00148	CcSEcCtD
Cysteamine—Fatigue—Risedronate—osteoporosis	0.000943	0.00148	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—MYC—osteoporosis	0.000942	0.00327	CbGpPWpGaD
Cysteamine—Constipation—Risedronate—osteoporosis	0.000935	0.00146	CcSEcCtD
Cysteamine—Diarrhoea—Alendronate—osteoporosis	0.000933	0.00146	CcSEcCtD
Cysteamine—Asthenia—Calcitriol—osteoporosis	0.000932	0.00146	CcSEcCtD
Cysteamine—Nervous system disorder—Zoledronate—osteoporosis	0.000932	0.00146	CcSEcCtD
Cysteamine—Immune system disorder—Estradiol—osteoporosis	0.000931	0.00146	CcSEcCtD
Cysteamine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000925	0.00145	CcSEcCtD
Cysteamine—Somnolence—Pamidronate—osteoporosis	0.000924	0.00145	CcSEcCtD
Cysteamine—Skin disorder—Zoledronate—osteoporosis	0.000923	0.00144	CcSEcCtD
Cysteamine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000917	0.00144	CcSEcCtD
Cysteamine—Diarrhoea—Raloxifene—osteoporosis	0.000917	0.00144	CcSEcCtD
Cysteamine—Dyspepsia—Pamidronate—osteoporosis	0.000915	0.00143	CcSEcCtD
Cysteamine—Dizziness—Estropipate—osteoporosis	0.000915	0.00143	CcSEcCtD
Cysteamine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000915	0.00143	CcSEcCtD
Cysteamine—Diarrhoea—Ibandronate—osteoporosis	0.000908	0.00142	CcSEcCtD
Cysteamine—Anorexia—Zoledronate—osteoporosis	0.000905	0.00142	CcSEcCtD
Cysteamine—Decreased appetite—Pamidronate—osteoporosis	0.000904	0.00141	CcSEcCtD
Cysteamine—Mental disorder—Estradiol—osteoporosis	0.000903	0.00141	CcSEcCtD
Cysteamine—Dizziness—Alendronate—osteoporosis	0.000902	0.00141	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000898	0.0014	CcSEcCtD
Cysteamine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000897	0.0014	CcSEcCtD
Cysteamine—Erythema—Estradiol—osteoporosis	0.000897	0.0014	CcSEcCtD
Cysteamine—Malnutrition—Estradiol—osteoporosis	0.000897	0.0014	CcSEcCtD
Cysteamine—Fatigue—Pamidronate—osteoporosis	0.000897	0.0014	CcSEcCtD
Cysteamine—Gastrointestinal pain—Risedronate—osteoporosis	0.000895	0.0014	CcSEcCtD
Cysteamine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000891	0.00139	CcSEcCtD
Cysteamine—Constipation—Pamidronate—osteoporosis	0.000889	0.00139	CcSEcCtD
Cysteamine—Diarrhoea—Calcitriol—osteoporosis	0.000889	0.00139	CcSEcCtD
Cysteamine—SST—Signaling Pathways—P4HB—osteoporosis	0.000889	0.00308	CbGpPWpGaD
Cysteamine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000888	0.00139	CcSEcCtD
Cysteamine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000887	0.00139	CcSEcCtD
Cysteamine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000887	0.00139	CcSEcCtD
Cysteamine—Dizziness—Raloxifene—osteoporosis	0.000887	0.00139	CcSEcCtD
Cysteamine—Tension—Estradiol—osteoporosis	0.00088	0.00138	CcSEcCtD
Cysteamine—Vomiting—Estropipate—osteoporosis	0.00088	0.00138	CcSEcCtD
Cysteamine—Dizziness—Ibandronate—osteoporosis	0.000878	0.00137	CcSEcCtD
Cysteamine—Rash—Estropipate—osteoporosis	0.000873	0.00137	CcSEcCtD
Cysteamine—Dermatitis—Estropipate—osteoporosis	0.000872	0.00136	CcSEcCtD
Cysteamine—Anorexia—Conjugated Estrogens—osteoporosis	0.000872	0.00136	CcSEcCtD
Cysteamine—Nervousness—Estradiol—osteoporosis	0.000871	0.00136	CcSEcCtD
Cysteamine—Urticaria—Risedronate—osteoporosis	0.000869	0.00136	CcSEcCtD
Cysteamine—Headache—Estropipate—osteoporosis	0.000867	0.00136	CcSEcCtD
Cysteamine—Vomiting—Alendronate—osteoporosis	0.000867	0.00136	CcSEcCtD
Cysteamine—Abdominal pain—Risedronate—osteoporosis	0.000865	0.00135	CcSEcCtD
Cysteamine—Body temperature increased—Risedronate—osteoporosis	0.000865	0.00135	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTH—osteoporosis	0.000864	0.003	CbGpPWpGaD
Cysteamine—Rash—Alendronate—osteoporosis	0.00086	0.00135	CcSEcCtD
Cysteamine—Dermatitis—Alendronate—osteoporosis	0.000859	0.00134	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL6—osteoporosis	0.000859	0.00298	CbGpPWpGaD
Cysteamine—Feeling abnormal—Pamidronate—osteoporosis	0.000857	0.00134	CcSEcCtD
Cysteamine—Headache—Alendronate—osteoporosis	0.000854	0.00134	CcSEcCtD
Cysteamine—Vomiting—Raloxifene—osteoporosis	0.000853	0.00133	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—P4HB—osteoporosis	0.000852	0.00295	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Pamidronate—osteoporosis	0.00085	0.00133	CcSEcCtD
Cysteamine—SST—Signaling Pathways—RAP1A—osteoporosis	0.000849	0.00294	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—osteoporosis	0.000848	0.00294	CbGpPWpGaD
Cysteamine—Rash—Raloxifene—osteoporosis	0.000845	0.00132	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—osteoporosis	0.000845	0.00293	CbGpPWpGaD
Cysteamine—Dermatitis—Raloxifene—osteoporosis	0.000845	0.00132	CcSEcCtD
Cysteamine—Somnolence—Zoledronate—osteoporosis	0.000844	0.00132	CcSEcCtD
Cysteamine—Vomiting—Ibandronate—osteoporosis	0.000844	0.00132	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CNR2—osteoporosis	0.000842	0.00292	CbGpPWpGaD
Cysteamine—Tremor—Estradiol—osteoporosis	0.00084	0.00131	CcSEcCtD
Cysteamine—Headache—Raloxifene—osteoporosis	0.00084	0.00131	CcSEcCtD
Cysteamine—Rash—Ibandronate—osteoporosis	0.000837	0.00131	CcSEcCtD
Cysteamine—Dermatitis—Ibandronate—osteoporosis	0.000836	0.00131	CcSEcCtD
Cysteamine—Dyspepsia—Zoledronate—osteoporosis	0.000836	0.00131	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—ADCY5—osteoporosis	0.000836	0.0029	CbGpPWpGaD
Cysteamine—Headache—Ibandronate—osteoporosis	0.000832	0.0013	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NFATC1—osteoporosis	0.000829	0.00287	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTH—osteoporosis	0.000829	0.00287	CbGpPWpGaD
Cysteamine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000827	0.00129	CcSEcCtD
Cysteamine—Vomiting—Calcitriol—osteoporosis	0.000826	0.00129	CcSEcCtD
Cysteamine—Decreased appetite—Zoledronate—osteoporosis	0.000826	0.00129	CcSEcCtD
Cysteamine—Agitation—Estradiol—osteoporosis	0.000824	0.00129	CcSEcCtD
Cysteamine—Nausea—Estropipate—osteoporosis	0.000822	0.00129	CcSEcCtD
Cysteamine—SST—Signaling Pathways—DKK1—osteoporosis	0.000822	0.00285	CbGpPWpGaD
Cysteamine—Body temperature increased—Pamidronate—osteoporosis	0.000822	0.00129	CcSEcCtD
Cysteamine—Abdominal pain—Pamidronate—osteoporosis	0.000822	0.00129	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00082	0.00128	CcSEcCtD
Cysteamine—Rash—Calcitriol—osteoporosis	0.000819	0.00128	CcSEcCtD
Cysteamine—Fatigue—Zoledronate—osteoporosis	0.000819	0.00128	CcSEcCtD
Cysteamine—Dermatitis—Calcitriol—osteoporosis	0.000819	0.00128	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—RAP1A—osteoporosis	0.000814	0.00282	CbGpPWpGaD
Cysteamine—Headache—Calcitriol—osteoporosis	0.000814	0.00127	CcSEcCtD
Cysteamine—Somnolence—Conjugated Estrogens—osteoporosis	0.000813	0.00127	CcSEcCtD
Cysteamine—Constipation—Zoledronate—osteoporosis	0.000812	0.00127	CcSEcCtD
Cysteamine—Nausea—Alendronate—osteoporosis	0.00081	0.00127	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CNR2—osteoporosis	0.000808	0.0028	CbGpPWpGaD
Cysteamine—Hypersensitivity—Risedronate—osteoporosis	0.000806	0.00126	CcSEcCtD
Cysteamine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000805	0.00126	CcSEcCtD
Cysteamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000805	0.00126	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—ADCY5—osteoporosis	0.000802	0.00278	CbGpPWpGaD
Cysteamine—Nausea—Raloxifene—osteoporosis	0.000796	0.00125	CcSEcCtD
Cysteamine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000795	0.00124	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NFATC1—osteoporosis	0.000794	0.00275	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—WNT1—osteoporosis	0.000792	0.00275	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00079	0.00124	CcSEcCtD
Cysteamine—Fatigue—Conjugated Estrogens—osteoporosis	0.000789	0.00123	CcSEcCtD
Cysteamine—Nausea—Ibandronate—osteoporosis	0.000788	0.00123	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—DKK1—osteoporosis	0.000788	0.00273	CbGpPWpGaD
Cysteamine—Asthenia—Risedronate—osteoporosis	0.000785	0.00123	CcSEcCtD
Cysteamine—Feeling abnormal—Zoledronate—osteoporosis	0.000783	0.00122	CcSEcCtD
Cysteamine—Constipation—Conjugated Estrogens—osteoporosis	0.000782	0.00122	CcSEcCtD
Cysteamine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000777	0.00122	CcSEcCtD
Cysteamine—Hypertension—Estradiol—osteoporosis	0.000774	0.00121	CcSEcCtD
Cysteamine—Nausea—Calcitriol—osteoporosis	0.000772	0.00121	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGA—osteoporosis	0.00077	0.00267	CbGpPWpGaD
Cysteamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000768	0.0012	CcSEcCtD
Cysteamine—Hypersensitivity—Pamidronate—osteoporosis	0.000766	0.0012	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—WNT1—osteoporosis	0.000759	0.00263	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ADCY5—osteoporosis	0.000759	0.00263	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000758	0.00119	CcSEcCtD
Cysteamine—Urticaria—Zoledronate—osteoporosis	0.000755	0.00118	CcSEcCtD
Cysteamine—Discomfort—Estradiol—osteoporosis	0.000754	0.00118	CcSEcCtD
Cysteamine—Body temperature increased—Zoledronate—osteoporosis	0.000751	0.00117	CcSEcCtD
Cysteamine—Abdominal pain—Zoledronate—osteoporosis	0.000751	0.00117	CcSEcCtD
Cysteamine—Diarrhoea—Risedronate—osteoporosis	0.000748	0.00117	CcSEcCtD
Cysteamine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000748	0.00117	CcSEcCtD
Cysteamine—Asthenia—Pamidronate—osteoporosis	0.000746	0.00117	CcSEcCtD
Cysteamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000742	0.00116	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGA—osteoporosis	0.000739	0.00256	CbGpPWpGaD
Cysteamine—Confusional state—Estradiol—osteoporosis	0.000738	0.00115	CcSEcCtD
Cysteamine—Anaphylactic shock—Estradiol—osteoporosis	0.000732	0.00115	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—ADCY5—osteoporosis	0.000728	0.00252	CbGpPWpGaD
Cysteamine—Urticaria—Conjugated Estrogens—osteoporosis	0.000727	0.00114	CcSEcCtD
Cysteamine—Dizziness—Risedronate—osteoporosis	0.000723	0.00113	CcSEcCtD
Cysteamine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000723	0.00113	CcSEcCtD
Cysteamine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000723	0.00113	CcSEcCtD
Cysteamine—Nervous system disorder—Estradiol—osteoporosis	0.000718	0.00112	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTHLH—osteoporosis	0.000716	0.00248	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—BMP2—osteoporosis	0.000716	0.00248	CbGpPWpGaD
Cysteamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000713	0.00112	CcSEcCtD
Cysteamine—Diarrhoea—Pamidronate—osteoporosis	0.000712	0.00111	CcSEcCtD
Cysteamine—Skin disorder—Estradiol—osteoporosis	0.000711	0.00111	CcSEcCtD
Cysteamine—Rash—Ethinyl Estradiol—osteoporosis	0.000707	0.00111	CcSEcCtD
Cysteamine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000707	0.00111	CcSEcCtD
Cysteamine—Headache—Ethinyl Estradiol—osteoporosis	0.000703	0.0011	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGB—osteoporosis	0.000701	0.00243	CbGpPWpGaD
Cysteamine—Hypersensitivity—Zoledronate—osteoporosis	0.0007	0.0011	CcSEcCtD
Cysteamine—Vomiting—Risedronate—osteoporosis	0.000696	0.00109	CcSEcCtD
Cysteamine—Rash—Risedronate—osteoporosis	0.00069	0.00108	CcSEcCtD
Cysteamine—Dermatitis—Risedronate—osteoporosis	0.000689	0.00108	CcSEcCtD
Cysteamine—Dizziness—Pamidronate—osteoporosis	0.000688	0.00108	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PTHLH—osteoporosis	0.000687	0.00238	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BMP2—osteoporosis	0.000687	0.00238	CbGpPWpGaD
Cysteamine—Headache—Risedronate—osteoporosis	0.000685	0.00107	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—osteoporosis	0.000682	0.00237	CbGpPWpGaD
Cysteamine—Asthenia—Zoledronate—osteoporosis	0.000682	0.00107	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PSMA5—osteoporosis	0.000677	0.00235	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PSMA2—osteoporosis	0.000677	0.00235	CbGpPWpGaD
Cysteamine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000674	0.00105	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGB—osteoporosis	0.000672	0.00233	CbGpPWpGaD
Cysteamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000666	0.00104	CcSEcCtD
Cysteamine—Vomiting—Pamidronate—osteoporosis	0.000661	0.00103	CcSEcCtD
Cysteamine—Asthenia—Conjugated Estrogens—osteoporosis	0.000656	0.00103	CcSEcCtD
Cysteamine—Rash—Pamidronate—osteoporosis	0.000656	0.00103	CcSEcCtD
Cysteamine—Dermatitis—Pamidronate—osteoporosis	0.000655	0.00103	CcSEcCtD
Cysteamine—Headache—Pamidronate—osteoporosis	0.000651	0.00102	CcSEcCtD
Cysteamine—Somnolence—Estradiol—osteoporosis	0.000651	0.00102	CcSEcCtD
Cysteamine—Diarrhoea—Zoledronate—osteoporosis	0.00065	0.00102	CcSEcCtD
Cysteamine—Nausea—Risedronate—osteoporosis	0.00065	0.00102	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PSMA2—osteoporosis	0.000649	0.00225	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PSMA5—osteoporosis	0.000649	0.00225	CbGpPWpGaD
Cysteamine—Dyspepsia—Estradiol—osteoporosis	0.000644	0.00101	CcSEcCtD
Cysteamine—Decreased appetite—Estradiol—osteoporosis	0.000636	0.000996	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000632	0.000989	CcSEcCtD
Cysteamine—Fatigue—Estradiol—osteoporosis	0.000631	0.000988	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CALCA—osteoporosis	0.000631	0.00219	CbGpPWpGaD
Cysteamine—Dizziness—Zoledronate—osteoporosis	0.000628	0.000983	CcSEcCtD
Cysteamine—Constipation—Estradiol—osteoporosis	0.000626	0.00098	CcSEcCtD
Cysteamine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000626	0.000979	CcSEcCtD
Cysteamine—Nausea—Pamidronate—osteoporosis	0.000618	0.000967	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—POMC—osteoporosis	0.000615	0.00213	CbGpPWpGaD
Cysteamine—Dizziness—Conjugated Estrogens—osteoporosis	0.000605	0.000946	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CALCA—osteoporosis	0.000605	0.0021	CbGpPWpGaD
Cysteamine—Vomiting—Zoledronate—osteoporosis	0.000604	0.000945	CcSEcCtD
Cysteamine—Feeling abnormal—Estradiol—osteoporosis	0.000603	0.000944	CcSEcCtD
Cysteamine—Rash—Zoledronate—osteoporosis	0.000599	0.000937	CcSEcCtD
Cysteamine—Gastrointestinal pain—Estradiol—osteoporosis	0.000599	0.000937	CcSEcCtD
Cysteamine—Dermatitis—Zoledronate—osteoporosis	0.000598	0.000936	CcSEcCtD
Cysteamine—Headache—Zoledronate—osteoporosis	0.000595	0.000931	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—POMC—osteoporosis	0.00059	0.00204	CbGpPWpGaD
Cysteamine—Vomiting—Conjugated Estrogens—osteoporosis	0.000582	0.00091	CcSEcCtD
Cysteamine—Urticaria—Estradiol—osteoporosis	0.000582	0.00091	CcSEcCtD
Cysteamine—Body temperature increased—Estradiol—osteoporosis	0.000579	0.000905	CcSEcCtD
Cysteamine—Abdominal pain—Estradiol—osteoporosis	0.000579	0.000905	CcSEcCtD
Cysteamine—Rash—Conjugated Estrogens—osteoporosis	0.000577	0.000902	CcSEcCtD
Cysteamine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000576	0.000902	CcSEcCtD
Cysteamine—Headache—Conjugated Estrogens—osteoporosis	0.000573	0.000897	CcSEcCtD
Cysteamine—SST—Signaling Pathways—KL—osteoporosis	0.000573	0.00198	CbGpPWpGaD
Cysteamine—Nausea—Zoledronate—osteoporosis	0.000564	0.000883	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—POMC—osteoporosis	0.000558	0.00194	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KL—osteoporosis	0.000549	0.0019	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6R—osteoporosis	0.000545	0.00189	CbGpPWpGaD
Cysteamine—Nausea—Conjugated Estrogens—osteoporosis	0.000543	0.00085	CcSEcCtD
Cysteamine—Hypersensitivity—Estradiol—osteoporosis	0.000539	0.000844	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—POMC—osteoporosis	0.000535	0.00186	CbGpPWpGaD
Cysteamine—Asthenia—Estradiol—osteoporosis	0.000525	0.000822	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL6R—osteoporosis	0.000522	0.00181	CbGpPWpGaD
Cysteamine—Diarrhoea—Estradiol—osteoporosis	0.000501	0.000784	CcSEcCtD
Cysteamine—Dizziness—Estradiol—osteoporosis	0.000484	0.000757	CcSEcCtD
Cysteamine—Vomiting—Estradiol—osteoporosis	0.000465	0.000728	CcSEcCtD
Cysteamine—Rash—Estradiol—osteoporosis	0.000462	0.000722	CcSEcCtD
Cysteamine—Dermatitis—Estradiol—osteoporosis	0.000461	0.000722	CcSEcCtD
Cysteamine—Headache—Estradiol—osteoporosis	0.000459	0.000718	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ADCY5—osteoporosis	0.000449	0.00155	CbGpPWpGaD
Cysteamine—Nausea—Estradiol—osteoporosis	0.000435	0.00068	CcSEcCtD
Cysteamine—SST—Signaling Pathways—SPP1—osteoporosis	0.000434	0.0015	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADCY5—osteoporosis	0.00043	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SPP1—osteoporosis	0.000416	0.00144	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IRS2—osteoporosis	0.000392	0.00136	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LEP—osteoporosis	0.000384	0.00133	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IRS2—osteoporosis	0.000376	0.0013	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LEP—osteoporosis	0.000368	0.00128	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ESR1—osteoporosis	0.000367	0.00127	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ESR1—osteoporosis	0.000352	0.00122	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IRS1—osteoporosis	0.000343	0.00119	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—POMC—osteoporosis	0.00033	0.00114	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IRS1—osteoporosis	0.000328	0.00114	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6R—osteoporosis	0.000322	0.00112	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1—osteoporosis	0.000317	0.0011	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—POMC—osteoporosis	0.000316	0.0011	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6R—osteoporosis	0.000309	0.00107	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1—osteoporosis	0.000304	0.00105	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—osteoporosis	0.000243	0.000841	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—osteoporosis	0.000233	0.000807	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—osteoporosis	0.000191	0.000661	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—osteoporosis	0.00019	0.00066	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—osteoporosis	0.000183	0.000634	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—osteoporosis	0.000182	0.000632	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—osteoporosis	0.000143	0.000497	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—osteoporosis	0.000137	0.000476	CbGpPWpGaD
